论文部分内容阅读
目的 观察卡托普利和钙拮抗剂治疗肺源性心脏病的临床效果。方法 91例肺心病患者随机分成 2组 ,治疗组 (6 0例 )在常规治疗的基础上加用卡托普利和钙拮抗剂口服 ;对照组 (31例 )常规基础治疗 ,包括洋地黄及利尿剂的应用。结果 治疗组有效率 (96 .7% )明显高于对照组 (77.4 % ) ,两组比较有显著差异 (P <0 .0 1)。结论 卡托普利和钙拮抗剂治疗肺心病安全有效 ,尤其适用于合并心力衰竭的患者。
Objective To observe the clinical effects of captopril and calcium antagonists in the treatment of pulmonary heart disease. Methods Ninety-one patients with pulmonary heart disease were randomly divided into two groups. The treatment group (60 cases) was treated with captopril and calcium antagonists on a routine basis. The control group (31 cases) received routine basic treatment including digitalis and diuretic Application of agents. Results The effective rate of the treatment group (96.7%) was significantly higher than that of the control group (77.4%). There was significant difference between the two groups (P <0.01). Conclusions Captopril and calcium antagonists are safe and effective in the treatment of pulmonary heart disease, especially for patients with heart failure.